Filing Flows › Invo Fertility (IVF) › Q3 2025
Invo Fertility (IVF) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 17, 2025
Invo Fertility (IVF) reported revenue of $1.8M for the third quarter 2025 (Q3 2025), +23% from a year earlier and -6% from the quarter before. Operating margin was -93.1%, net loss $1.7M (98.4% of revenue).
Invo Fertility, Q3 2025: revenue $1.8M (+23% year over year), operating margin -93.1%, net loss $1.7M, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.8M | -6% | +23% |
| Operating profit | −$1.6M | — | — |
| Net earnings | −$1.7M | — | — |
| Operating cash flow | −$1.8M | — | — |
What changed
Revenue was $1.8M in Q3 2025, up 23% year over year and down 6% from the previous quarter. Clinic Revenue was the largest line at 98% of revenue. Clinic Revenue added $304K year over year (up 21%), 94% of the total change.
Operating costs exceeded revenue by $1.6M, an operating margin of -93.1%. Total costs grew 24% against revenue growth of 23%. The fastest-growing cost line was Other operating costs (+449%). The quarter ended with a net loss of $1.7M, narrower than the previous quarter's $6.8M loss. Net interest and other expense of $1.0M was the main reason.
Operating cash flow was −$1.8M. Non-cash charges added back $137K of depreciation and amortization. Working capital and other items used $184K. Capital expenditures of $8K exceeded it, leaving free cash flow of −$1.8M.
Questions
What was Invo Fertility's revenue in the third quarter 2025?
Invo Fertility (IVF) reported revenue of $1.8M for the third quarter 2025 (Q3 2025), +23% from a year earlier and -6% from the quarter before.
Was Invo Fertility profitable in the third quarter 2025?
Operating loss was $1.6M (-93.1% of revenue) and net loss $1.7M.
Source: Invo Fertility 10-Q on SEC EDGAR.